A mutant of Escherichia coli harboring a temperature-labile phosphoribosylpyrophosphate (PRPP) synthetase was characterized. Despite the lack of a detectable PRPP pool or PRPP synthetase activity at 40°C, the strain was fully viable at this temperature as long as guanosine, uridine, histidine, tryptophan, and nicotinamide mononucleotide were all added to the growth medium. Viability of the strain was dependent upon mutations in genes of the nucleoside salvage pathways that improved the utilization of exogenous nucleosides. The properties of the strain are those expected of a PRPP-less strain and suggest that PRPP synthetase is dispensable for E. coli.
The metabolite 5-phospho-D-ribosyl-a-1-pyrophosphate (PRPP) is a biosynthetic precursor of purine and pyrimidine nucleotides, the pyridine nucleotide coenzyme NAD, and the amino acids histidine and tryptophan (8) . In nucleotide synthesis, PRPP is used in the de novo pathways as well as in the auxiliary pathways by which bases are converted to the nucleotides. Thus, in Escherichia coli 10 enzymes utilize PRPP as a substrate (Fig. 1A) . The synthesis of PRPP is catalyzed by PRPP synthetase (ATP:D-ribose-5-phosphate pyrophosphotransferase, EC 2.7.6.1) as follows: ribose 5-phosphate + ATP --PRPP + AMP. This enzyme, encoded by the prs gene (4) (5) (6) , is believed to be essential for the growth of all organisms. The ultimate products of some of the PRPP pathways, i.e., purine and pyrimidine nucleotides, are impermeable to cells and therefore cannot be fed exogenously. Instead, in E. coli wild-type cells the nucleotides and nucleosides are catabolized rapidly to the nucleobases, and the nucleobases in turn are converted intracellularly to the nucleotides by consumption of PRPP (Fig. 1B) (3, 12, 14) . Moreover E. coli cells are impermeable to PRPP. In the present work, I describe conditions under which PRPP is apparently dispensable. These conditions were achieved by using a strain with a temperature-sensitive mutation within the prs gene and by mutational manipulation of the nucleoside salvage pathways, so that the ribonucleosides were directly phosphorylated to ribonucleotides rather than degraded to nucleobases. As a consequence of these mutations, the strain had a simultaneous requirement for purine, pyrimidine, and pyridine compounds as well as for histidine and tryptophan.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The E. coli K-12 strains used are shown in Table 1 . Standard genetic techniques were used (4) . The udp, deoD, and gsk alleles were manipulated in a hemA prs+ host strain which was then transduced to hem' with a bacteriophage P1 lysate grown on H0541 (prs-2) (5), and isogenic hem' prs-2 and hem' prs+ strains were obtained. The markers hemA and prs are very closely linked (4) . The manipulation of the markers was performed in a hemA prs+ strain, rather than in a prs-2 strain, to avoid eventual counterselection of prs-2. Strains harboring prs-2 were maintained at 25°C. All udp strains contained the udp::TnS allele originally present in strain AM427 (A. Mironov, unpublished data), whereas all deoD strains contained the allele from strain S0446 (4) . The gsk-3 allele was selected as described previously (7) . The strains also contained metB relA spoT supF lamB rpsL and were derived from the defined wild-type strain S0003 (4) . Growth curves were obtained by culturing the cells in the phosphatebuffered AB minimal salt medium of Clark and Maal0e (1) . Glucose (0.2%) was used as the carbon source. Methionine (40 mg/liter) and thiamine (0.5 mg/liter) were added to all growth media. When indicated, the following compounds were added: guanosine (30 mg/liter), uridine (20 mg/liter), histidine (40 mg/liter), tryptophan (40 mg/liter), and nicotinamide mononucleotide (NMN; 33 mg/liter). Growth was recorded as absorbance in an Eppendorf photometer at 436 nm. An A436 of 1 (1-cm light path) corresponds to approximately 3 x 108 cells per ml.
Determination of PRPP and ribonucleoside triphosphate pools. Cells were grown in Tris-buffered minimal medium containing 0.3 mM Pi (9) . After at least six generations of exponential growth, carrier-free 32p; (Fors0gsanlaeg Ris0, Denmark) was added to a specific radioactivity of 1.1 to 4.8 TBq/mol. After approximately three generations of growth, samples were removed, and the PRPP and ribonucleoside triphosphates were extracted and separated by two-dimensional thin-layer chromatography on polyethyleneimine-impregnated cellulose plastic sheets (9) . After the radioactive spots were identified by autoradiography, they were cut out, and the radioactivity was determined by liquid scintillation counting.
Assay of PRPP synthetase activity. Cells were grown exponentially in AB medium. At 10 ,ul were intervals (1, 5, 10 , and 20 min), mixed with 5 HCOOH, and applied to polyethyleneimine-ce layer chromatographic plates. After drying, th4 grams were developed in 0.85 M KH2PO4 (adji 3.4 with 0.85 M H3PO4). After autoradiograph spots were cut out, and the radioactivity was de liquid scintillation counting (9) . The protein e determined with bovine serum albumin as the st
RESULTS
Rationale for establishing presumptive PRPI tions. Because of the various pathways that util PRPP-less strain becomes phenotypically PurTrp-Nad- (Fig. 1A ) and needs to be supplied nous sources of purine, pyrimidine, and pyridine together with histidine and tryptophan. Purine dine compounds are most conveniently offered nucleosides. However, complex pathways e: metabolism of ribonucleosides (Fig. 1B) . Wilddegrade the nucleosides to the bases, catalyzec side phosphorylases (3). The base moieties in I converted to nucleotides by consumption of PR] tively, the ribonucleosides can be phosphorylate the ribonucleotides by ribonucleoside kinaseL rolysis (i.e., degradation) is much more predo phosphorylation, and under PRPP-less conditioi osides are almost exclusively converted to bas (3, 12, 14) . Mutational inactivation of uridine ph (udp) and purine nucleoside phosphorylase (de the degradation of the nucleosides, and the kina reactions are the sole functioning pathways oi metabolism. Uridine and guanosine, therefor verted to UMP and GMP exclusively via phosph uridine kinase (udk) and guanosine kinase (g tively; i.e., purine and pyrimidine nucleotides i Nucleobase thesized by PRPP-independent pathways (Fig. 1B and C) (12, 14) . In the case of purine nucleosides, a deoD mutation is not sufficient for efficient utilization of guanosine. Thus, Nucside pur deoD strains cannot use purine ribonucleosides as the sole purine source (7, 10, 14) , and it might be expected that a PRPP-less (Pur-) deoD strain could not be supplemented Figure 2 usted to pH shows the response obtained when the prs-2 strain and an y the PRPP isogenic prs+ strain were grown at 40°C in a medium termined by containing all five compounds and shifted to media lacking content was one of the compounds. Removal of either one of the nucleoandard (11) osides or one of the amino acids caused a rapid cessation of growth of the prs-2 strain, whereas removal of NMN caused a slow cessation, typical of deprivation of a vitamin ( Fig.  2A) . Growth of the prs+ strain did not change, except for a small stimulation in the absence of uridine (Fig. 2B) . The P-less condiprs-2 strain may be regarded as an auxotrophic strain, lize PRPP, a requiring the simultaneous addition of guanosine, uridine, Pyr-Hishistidine, tryptophan, and NMN ( Fig. 2A) (Table 2) . At 20°C, the pool sizes of the prs-2 strain were close to those of the wild-type strain, except that the PRPP pool was reduced to 50%. However, this reduction in the PRPP pool did not result in slower growth; the two strains grew at identical rates. At 30°C, the PRPP pool of the prs-2 strain was greatly reduced, whereas the ribonucleoside triphosphate pool sizes, except that of ATP, were nearly normal as compared with H0608 (prs+) at 30°C. Finally, at 40°C the prs-2 strain contained no detectable PRPP. Under these conditions, the purine ribonucleoside triphosphate pools were somewhat reduced, whereas the pyrimidine ribonucleoside triphosphate pools were much less abnormal. Despite the lack of a detectable PRPP pool, the prs-2 strain showed exponential growth, although at a reduced rate compared with the otherwise isogenic prs+ strain.
The lack of PRPP in the prs-2 strain was caused by nonfunctioning of PRPP synthetase (Table 2 ). H0609 (prs-2) contained no assayable PRPP synthetase activity in extracts of cells grown at 40°C. The PRPP synthetase activity in H0609 grown at 30°C was 15% of the activity in the prs+ strain, whereas the PRPP pool in the prs-2 strain was only a few percent of the PRPP pool in the wild-type strain. Also, when cells were grown at 20°C the PRPP synthetase activity of the prs-2 strain was reduced as compared with the prs+ strain.
Effect of the mutations in udp, deoD, and gsk. prs-2 and prs+ strains that lacked the various mutant alleles were constructed (Table 1 ). Figure 3A shows the behavior of these prs-2 strains grown at 25°C and shifted to 40°C with all the required components present. From the data given in Table  2 , it is expected that the prs-2 cells exhaust their PRPP pool after the shift in the temperature. Strain H0609 continued exponential growth with a stimulation in growth rate upon the shift. The deo+ strain (HO637) displayed a quite different growth curve. This strain stopped growing after two to three generations of exponential growth. At this time, all of the added guanosine had been incorporated into nucleic acids or converted to purine bases, which cannot be converted to nucleotides if there is no PRPP available. In addition lack of PRPP prevents de novo purine synthesis. The guanosine salvage pathways of strain H0637 compared with those of strain H0609 are illustrated in Fig. 4A . In contrast, the gsk+ derivative (H0635) immediately ceased exponential growth upon the shift, and the culture became stationary after about 12 h of incubation. The reason for the lack of growth of H0635 at 40°C is that guanosine is not properly salvaged, due to inefficiency of the wild-type guanosine kinase, and there is no PRPP available for de novo purine nucleotide synthesis. The guanosine salvage pathways of strain H0635 are given in Fig. 4A Tirne (h) FIG. 3 . Effect of gsk-3, deoD, and udp mutations on the growth of the prs-2 strain. Cells were grown at 25'C in AB minimal medium with guanosine, uridine, histidine, tryptophan, and NMN present. After at least five generations of exponential growth, at an A436 of 0.8, cell cultures were diluted 20-fold (arrows) into identical medium prewarmed at 40°C, and growth was continued at 40'C. (A) Response of the prs-2 strains H0609 (udp deoD gsk-3 prs-2), H0635 (udp deoD gsk+ prs-2), H0637 (udp deo+ gsk-3 prs-2), and H0639 (udp+ deoD gsk-3 prs-2). (B) Response of the prs+ strains H0608 (udp deoD gsk-3), H0634 (udp deoD gsk+), H0636 (udp deo+ gsk-3), and H0638 (udp+ deoD gsk-3).
postshift is inactive. In fact, after an upshift in temperature, the specific activity of PRPP synthetase decreased in a manner reciprocal to the growth curve of strain H0635 (data not shown). Figure 3B shows the results of similar growth experiments with the prs+ strains that were otherwise isogenic with those used for Fig. 3A . These prs+ strains did not require any of the added compounds, and there was no cessation of growth beyond the shift in the temperature of strain H0608, H0634, or H0636. The udp+ strains (HO639 [prs-2] in Fig. 3A , H0638 [prs+] in Fig. 3B ) slowed growth at 25°C even before reaching the cell density of the temperature shift, indicating rapid phosphorolysis of uridine to uracil and ribose 1-phosphate (Fig. 4B) . The reason for this behavior is at present unknown. However, it seems to be partly due to the presence of the gsk-3 allele, which in some way causes inhibition of the pyrimidine de novo synthesis when guanosine is present and uridine absent (data not shown).
DISCUSSION
The pool and enzyme analyses described above show that an organism under certain conditions may be completely The results of analysis of the growth of this strain indicate that there is a hierarchy in the utilization of PRPP by the various pathways. Thus, removal of the nucleosides is lethal to the prs-2 strain at all temperatures. Removal of the amino acids is much less severe, and removal of NMN is even less severe. This effect, likely, is a composite of the efficiency with which PRPP is used by the pathways and of the quantitative demand of PRPP for the various PRPP end products. It has been calculated that purine and pyrimidine nucleotide synthesis each consume 30 to 40% of the PRPP synthesized, histidine and tryptophan each consume 10 to 15% whereas only 1 to 2% is used for NAD synthesis (8) . The results furthermore confirm the accumulated information about PRPP as precursor in the purine, pyrimidine, and pyridine nucleotide pathways and in histidine and tryptophan biosynthesis. In addition, the fact that strain H0609 is viable only when supplied with the relevant compounds demonstrate that no PRPP-utilizing pathways have been overlooked. 
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The results presented in Fig. 3A show that the presence of the gsk-3 allele is indispensable for establishing the phenotype of H0609, i.e., growth at 40°C in the presence of guanosine, uridine, histidine, tryptophan, and NMN. The mutant deoD allele is semidispensable; its presence improves the growth properties of the strain. The strains harboring the deoD+ allele only inefficiently utilize guanosine, but this inefficiency can be overcome by increasing the guanosine concentration. The mutant udp allele was also necessary to achieve optimal growth of the prs-2 strain. The udp allele was also required by the prs+ strain, so that the impact of udp on prs-2 could not be directly assessed.
The results obtained by analysis of strain H0609 at the restrictive temperature are those expected for a strain that is completely defective in PRPP synthesis: (i) no detectable PRPP pool or PRPP synthetase activity; (ii) requirement for purine, pyrimidine, and pyridine compounds and for histidine and tryptophan; and (iii) impaired growth when the nucleosides can be cleaved to the nucleobases. These results very strongly suggest that PRPP, and therefore PRPP synthetase activity, is dispensable for E. coli. Proof of this hypothesis, however, depends on the isolation of a true null mutation in the prs gene, i.e., a nonsense, an insertion, or a deletion mutation. An implication of the results is that prs mutants may be obtained by screening mutants for simultaneous requirements for purine, pyrimidine, and pyridine compounds as well as for histidine and tryptophan in a deoD udp gsk-3 genetic background.
The experiments described in the present work are based on a detailed knowledge of the nucleoside salvage pathways as they occur in E. coli. The rationale, i.e., the exchange of nucleoside phosphorylase reactions by nucleoside kinase reactions, may be valid in other organisms as well. However, in organisms that do not possess ribonucleoside kinases, it would not be possible to supply nucleotides without the intermediate formation of nucleobases, and thus PRPPless conditions may not be established. Whereas pyrimidine ribonucleoside kinases are widely distributed among microorganisms (12), purine ribonucleoside kinases have been discovered only in E. coli and Salmonella typhimurium (14) .
